Who invested in Genomind

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$11Mraised across 2 rounds since 2014, from 2 sources

$5.0MSeries A$6.0MSeries B

Latest round: Series B, $6.0MSept 2015
Step-upi: 1.2×
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015

$5.0MSeries A$6.0MSeries B

First round: Series A, $5.0M
Biggest round: $6.0M
Between rounds: 17 months

The rounds

Sept 2015
Series B$6.0M1 returning
- Claritas Capital
From a historical funding recordSEC filing: $12M sold, first sale Apr 2014
Apr 2014
Series A$5.0M1 new
- Claritas Capital
From a historical funding recordSEC filing: $2.3M sold, first sale Apr 2014

Founders and team

From Genomind's own website and the SEC filings it signed: 5 on the team.

Bill BrownChief Executive Officer
Shawn Patrick O'BrienMr. O'Brien is the Chief Executive Officer and the Chairman of the Board of the Issuer.i
María José SpringerChief Operating Officer
Tom Patrick HessMr. Hess is the Chief Financial Officer and Secretary of the Issuer.i
Stephen Patrick HallerMr. Haller is the Treasurer of the Issuer.i

On the board, as filediBeth Patrick DozoretzJohn Patrick ChadwickShelloy Patrick KigerTheresa Patrick Sexton

Everyone who backed them

Claritas CapitalVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Genomind as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.